Last year was the 10th anniversary of Ralph Steinman’s Nobel Prize awarded for his discovery of dendritic cells (DCs), while next year brings the 50th anniversary of that discovery. Current models of anti-viral and anti-tumor immunity rest solidly on Steinman’s discovery of DCs, but also rely on two seemingly unrelated phenomena, also reported in the mid-1970s: the discoveries of “help” for cytolytic T cell responses by Cantor and Boyse in 1974 and “cross-priming” by Bevan in 1976. Decades of subsequent work, controversy, and conceptual changes have gradually merged these three discoveries into current models of cell-mediated immunity against viruses and tumors.

Original languageEnglish
Article numbere20211519
JournalJournal of Experimental Medicine
Issue number7
StatePublished - Jul 4 2022


Dive into the research topics of 'DCs at the center of help: Origins and evolution of the three-cell-type hypothesis'. Together they form a unique fingerprint.

Cite this